Episode
JAMA Neurology : Gefurulimab and Generalized Myasthenia Gravis
- Podcast
- JAMA Network
- Published
- Jul 27, 2026
- Duration seconds
- 1002
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/jama-network-1057758/episodes/jama-neurology-gefurulimab-and-generalized-myasthenia-gravis/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/jama-network-1057758/jama-neurology-gefurulimab-and-generalized-myasthenia-gravis.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy